help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 1, 2007
Endocrinology, doi:10.1210/en.2006-1676
A more recent version of this article appeared on June 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
148/6/2815    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ronkainen, J. J
Right arrow Articles by Tavi, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ronkainen, J. J
Right arrow Articles by Tavi, P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL

Submitted on December 14, 2006
Accepted on February 21, 2007

CaMKII is the common factor in calcium dependent cardiac expression and secretion of A- and B-type natriuretic peptides

Jarkko J Ronkainen, Olli Vuolteenaho, and Pasi Tavi*

Department of Physiology and Biocenter Oulu, University of Oulu, Finland

* To whom correspondence should be addressed. E-mail: pasi.tavi{at}oulu.fi.

Peptides derived from the precursor of A- and B-type natriuretic peptides (ANP and BNP) are powerful clinical markers of cardiac hypertrophy and dysfunction. It is known that many stimuli affecting the intracellular calcium concentration also induce ANP and BNP secretion. It was our intention to study the mechanisms by which calcium regulates the secretion of ANP and BNP. The effects of pacing and calcium-calmodulin kinase II (CaMKII) activity on NP secretion were studied in isolated perfused rat atria and in cultured rat neonatal cardiomyocytes. In isolated rat atrium pacing induced an increase in diastolic, systolic and averaged [Ca2+]i and a frequency-dependent increase in the secretion of both ANP and BNP. The molar ratio of the secreted NPs (ANP/BNP) remained nearly constant ({approx} 1000) at all the pacing frequencies tested (1 Hz, 3 Hz, 6 Hz and 8 Hz). Calmodulin kinase II inhibitor KN-93 (3 µM) did not affect [Ca2+]i, but showed a frequency-dependent inhibitory effect on ANP and BNP secretion without a change in ANP/BNP-ratio. In the neonatal cardiomyocytes, KN-93 (3 µM) suppressed the secretion and gene expression of both ANP and BNP. Overexpression of constitutively active (T286D) or nuclear ({delta}B) CaMKII induced an increase in ANP and BNP gene expression. The results indicate that the calcium dependent secretion and gene expression of A- and B-type natriuretic peptides are similarly regulated by calmodulin kinase II-dependent mechanisms. This is a plausible mechanism contributing to exercise-induced natriuretic peptide secretion and the augmented secretion in heart dysfunction due to impaired calcium handling.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society